Senior Medical Director
Dr. Karin Ganlöv is since August 2019 accountable for regulatory and pharmacovigilance related issues at Isofol, and she served as Chief Medical Officer before her new areas of responsibilities. Karin is a medical doctor (MD) from Lund University. She is specialized/board certified in cardiothoracic surgery and has research experience from the field of inflammatory diseases. The last 13 years she has worked in the pharmaceutical and medical device industry, initially as a medical advisor within her field of expertise, and the last 8 years as Medical Director, of which the last 5 years was in a role with corporate and global responsibility.
Karin joined Isofol in 2015.
Position: Senior Medical Director
Phone: (+46)702 433 750